Term ended no later than May 6, 2024 · Medium confidence
20-year base term ended May 6, 2024
USPTO later recorded it as expired for non-payment on Jan 13, 2025.
May 6, 2004
May 6, 2024
Dec 11, 2012
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 6, 2004, when application 10/841,250, the earliest non-provisional in its chain, was filed (this one was filed Nov 23, 2010) | May 6, 2024 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | term ended | High confidence |
| USPTO status record | Recorded as expired for non-payment on Jan 13, 2025, after the term ended | no change | High confidence |
| Computed term end | The steps above, in order | no later than May 6, 2024 | Medium confidence |
This family
| US 7,404,956 | In force Jun 2028 | Jun 2028 |
| US 7,348,004 | In force Mar 2028 | Mar 2028 |
| Application PCT/US2006/000140 | PCT application no patent term | no patent term |
| US 7,862,820 | Term ended no later than Mar 2026 | no later than Mar 2026 |
| US 8,329,182 | this patent no later than May 2024 | no later than May 2024 |
| US 8,932,830 | Term ended May 2024 | May 2024 |
| US 9,636,416 | Term ended May 2024 | May 2024 |
| US 11,401,322 | Term ended May 2024 | May 2024 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 24, 2011 Reel 25683, frame 238 | Peters, Robert T.; Mezo, Adam R.; Rivera, Daniel S.; Bitonti, Alan J.; Stattel, James; Low, Susan C. | Syntonix Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Apr 24, 2014 Reel 32753, frame 837 | Syntonix Pharmaceuticals, Inc. | Biogen Idec Hemophilia Inc. | Change of Name |
| Apr 30, 2015 Reel 35553, frame 325 | Biogen Idec Hemophilia Inc. | Biogen Hemophilia Inc. | Change of Name |
| Jul 2, 2015 Reel 36051, frame 773 | Biogen Hemophilia Inc. | Biogen Hemophilia Inc. | Change of Address |
| Feb 16, 2017 Reel 41735, frame 621 | Biogen Hemophilia Inc. | Bioverativ Therapeutics Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than May 6, 2024. We will not guess the cap.